Lentivirus production service and vector service selection: titre, purity and documentation

Making vector in house consumes containment space, plasmid and a person, and for occasional needs a service is faster and cheaper. What a service delivers varies enormously, and the difference is in the titre method, the purity and whether the paperwork lets you use the material for what you intended.

the biosafety manual that decides handling for biological material
BMBL
good laboratory practice for nonclinical studies, 21 CFR
Part 58
the labelling clause behind research use only on a reagent
809.10(c)

The figures in this panel are regulation and standard identifiers, named from the documents themselves and linked below. They are not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a price index it has not measured.

Ordering vector

  1. Name the titre method in the order. Physical particle, genome and functional titres differ by large factors, and only a functional titre on a cell type like yours predicts what you will get. Specify it, and specify the cell line it is measured on.
  2. Specify purity for the target cells. Crude supernatant is adequate for robust lines and inadequate for primary cells, where residual medium components and cellular debris cause toxicity. Concentrated and purified preparations exist for that reason.
  3. Ask what capsid content is reported for adeno associated vector. Full to empty ratio changes the effective dose and the immune load. A titre with no capsid content figure describes half the product.
  4. Confirm containment and shipping before ordering. Vector arrives under containment requirements and institutional approval, and the paperwork has to exist before the box does. This is the commonest cause of a delayed start.
  5. Order the controls with the vector. An empty or non targeting construct made in the same run is the control that matters, because it shares the preparation and its contaminants. Ordering it later gives a control from a different batch.
  6. Agree what happens on a low titre batch. Titre varies between productions. Whether a low batch is remade, credited or accepted with an adjusted dose should be settled in the order rather than after it.

Titre is a negotiated number

Because methods differ so widely, a titre only means something with its method attached. Two suppliers quoting the same figure can be measuring quantities that differ by more than an order of magnitude.

Fix the method in the order and, once, measure a batch yourself on your own cells. That single calibration makes every subsequent order interpretable.

Approvals are the schedule risk

Institutional biosafety approval, import and shipping paperwork and receiving arrangements take longer than production for many groups, and they are entirely administrative.

Start them when the vector is designed, not when it is ordered. It is the cheapest schedule protection available in this area.

The construct decides most of the outcome

Promoter choice, whether the cassette is inducible, the selection marker and the presence of a reporter are decided before anything is packaged and they decide whether the experiment works. A strong constitutive promoter silences in some cells; a weak one gives expression too low to see.

Insert size matters too, since packaging efficiency falls as the genome approaches its limit, and a large cassette with a selection marker and a reporter frequently crosses it. Trimming the cassette is usually cheaper than troubleshooting a low titre.

Knockdown needs the controls designed in

A knockdown result needs a non-targeting control delivered and selected identically, more than one independent sequence against the target, and a rescue where the phenotype matters. None of these can be added afterwards, because the comparison is between cells treated in parallel.

Where an inducible cassette is used, the uninduced arm is the cleanest control available, since the same cells serve as their own comparison. That is worth the extra construction effort in any experiment whose conclusion rests on the knockdown.

Libraries are a different operation

A pooled library has to be delivered at low multiplicity so that most cells receive one construct, at a coverage that keeps every member represented, and sequenced before and after selection. The arithmetic of coverage and cell number is the experiment's design.

An arrayed format trades scale for interpretability: one construct per well, a readout per well, no sequencing. Which to choose follows whether the readout can be a survival or reporter signal in a pool or has to be observed per construct.

Functional titre, multiplicity and transduction enhancers

A functional titre on your own cells is the only titre that predicts the transduction you will get, because permissiveness varies enormously between cell types. A titre measured on a standard line is a starting point for a dilution series, not a dose.

Cationic polymers and related enhancers improve transduction of resistant cells and are toxic at the concentrations that help most, so they need titrating with a viability readout. Spinoculation and medium changes often achieve as much without the toxicity.

The envelope decides what the particle can enter

A vector is pseudotyped with an envelope protein from another virus, and the commonest choice binds a receptor present on almost every cell type, which gives broad tropism and a robust particle that survives concentration. That breadth is why it is the default.

It is also why the particles infect the people handling them, so the containment level is set by the envelope and the insert rather than by the vector backbone. An alternative envelope narrows tropism deliberately, which is a design choice rather than a limitation.

Packaging in house or buying it

Packaging needs a suitable cell line, a plasmid set, transfection reagent, concentration and titration, and a facility approved for the work. For a laboratory producing vector regularly that is worth establishing; for one that needs a few constructs it is not.

A service delivers a titred preparation of your construct, usually faster than a laboratory learning the process. Compare on functional titre, the volume delivered, whether concentration is included and what quality control accompanies it rather than on price per tube.

adenovirus production, and how it differs from a lentiviral prep

Adenoviral vectors are produced in a permissive line that supplies the deleted functions, they replicate to high titre and are released by lysing the cells, and they are purified on a caesium chloride gradient or by anion exchange and quantified by particle and infectious titre. A lentiviral prep is the opposite in every respect that matters operationally: the particles are secreted into the medium, they are fragile, titre is orders of magnitude lower and the product integrates. The consequences are different containment, different purification and a different potency assay.

A lentivirus vector, and the parts of the construct

A lentiviral vector is a transfer construct stripped of everything the virus needs to replicate: the long terminal repeats, usually self-inactivating, a packaging signal, the central polypurine tract and an internal promoter driving your cassette, with a WPRE at the end to raise expression. What it has to leave out is as important as what it carries, since the accessory and structural genes come from separate packaging plasmids. Cassette size is the practical limit, because titre falls as the genome grows past about eight or nine kilobases.

lentiviral plasmids, and what each one supplies

A lentiviral preparation needs three or four plasmids and each supplies a distinct part. The transfer plasmid carries your cassette between self-inactivating long terminal repeats with the packaging signal. The packaging plasmid or plasmids supply gag, pol and, in third generation systems, rev on its own. The envelope plasmid supplies the glycoprotein, usually VSV-G, which sets tropism. Ratios are tuned per system and the transfer plasmid is the one whose quality decides titre, since the repeats are unstable in propagation and a truncated one packages badly.

A lentivirus packaging service, and what it delivers

A packaging service takes your transfer plasmid and returns titred virus, which is a sensible purchase because the co-transfection, the harvest timing and the concentration step are where most in-house preparations lose titre. What to specify is the envelope, the scale in transducing units rather than millilitres, whether the material is concentrated and in what buffer, and the testing, titre by transduction or by genome copies, sterility, and mycoplasma. For anything going into primary cells ask about the endotoxin and residual plasmid, since those are what the cells actually notice.

293t cells lentivirus production runs on, and why

HEK293T is the standard producer because it carries the SV40 large T antigen, which drives episomal replication of plasmids with an SV40 origin and so raises expression of the packaging components, and because it transfects at very high efficiency and grows fast. The practical consequences are that passage number and confluence at transfection move titre more than most protocol variables, that the line drifts if it is kept too long, and that a producer culture is kept separate from experimental cells. A suspension-adapted derivative is what a larger preparation moves to.

A lentiviral system, and what the phrase includes

A lentiviral system is the set of plasmids and cells that make the vector work together, and a generation label describes how the work is divided. A third generation system separates gag-pol, rev and the envelope onto their own plasmids and uses a self-inactivating transfer construct, which is what most institutional committees expect. Buying a system rather than assembling one is sensible because the ratios and the producer line are matched and the safety documentation exists, and the practical question is whether the transfer plasmid's cloning sites suit the cassette you have.

Common questions

Should I make or buy lentivirus?
Buy for occasional needs, for primary cell work needing purified material, and where containment space is scarce. Make when production is frequent enough to justify the containment, the plasmid and the person.
Which titre matters?
The functional titre on a cell type resembling yours. Physical particle counts are much higher and do not predict transduction, and comparing suppliers on unnamed titres compares nothing.
Why order a control construct in the same batch?
Because it shares the production, the purification and any contaminants. A control from another batch controls for the construct and not for the preparation.
Why is my transduction efficiency low?
Usually the cell type or the cassette. Measure a functional titre on your own cells rather than relying on one from a standard line, and check the insert size, since packaging falls as the genome approaches its limit.
In house or buy packaged vector?
Buy it unless you produce regularly: a service delivers a titred preparation faster than a laboratory learns the process. Compare on functional titre, volume, whether concentration is included and the quality control.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/lentivirus-production-service/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices